Identification of Linear Heparin-Binding Peptides Derived from Human Respiratory Syncytial Virus Fusion Glycoprotein That Inhibit Infectivity

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Virology

• Publication date

  2006-10-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/JVI.01226-06PMID 17050595PMCID PMC1797247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Respiratory syncytial virus and metapneumovirus

  2007cited by this paper
• Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression

  2005cited by this paper
• Herpes Simplex Virus Glycoprotein B Binds to Cell Surfaces Independently of Heparan Sulfate and Blocks Virus Entry

  2005cited by this paper
• Murine Coronavirus with an Extended Host Range Uses Heparan Sulfate as an Entry Receptor

  2005cited by this paper
• Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures

  2005cited by this paper
• The Soluble Form of Human Respiratory Syncytial Virus Attachment Protein Differs from the Membrane-Bound Form in Its Oligomeric State but Is Still Capable of Binding to Cell Surface Proteoglycans

  2004cited by this paper
• Common E Protein Determinants for Attenuation of Glycosaminoglycan-Binding Variants of Japanese Encephalitis and West Nile Viruses

  2004cited by this paper
• Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response

  2003cited by this paper
• Different Heparan Sulfate Proteoglycans Serve asCellular Receptors for HumanPapillomaviruses

  2003cited by this paper
• Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells.

  2003cited by this paper
• Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus.

  2002influential reference
• The Central Conserved Cystine Noose of the Attachment G Protein of Human Respiratory Syncytial Virus Is Not Required for Efficient Viral Infection In Vitro or In Vivo

  2002influential reference
• Proteolytic Activation of Respiratory Syncytial Virus Fusion Protein

  2001cited by this paper
• Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin.

  2001cited by this paper
• CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

  2001cited by this paper
• Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection.

  2001cited by this paper
• Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.

  2001cited by this paper
• A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3

  2000cited by this paper
• Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans.

  2000cited by this paper
• Structural characterization of the human respiratory syncytial virus fusion protein core.

  2000cited by this paper
• Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection

  2000influential reference
• Proteoglycans in the developing brain: new conceptual insights for old proteins.

  2000cited by this paper
• Lung Surfactant Protein A Provides a Route of Entry for Respiratory Syncytial Virus into Host Cells

  2000cited by this paper
• The Fusion Glycoprotein of Human Respiratory Syncytial Virus Facilitates Virus Attachment and Infectivity via an Interaction with Cellular Heparan Sulfate

  2000influential reference
• Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.

  2000cited by this paper
• The Core of the Respiratory Syncytial Virus Fusion Protein Is a Trimeric Coiled Coil

  2000cited by this paper
• Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity.

  1999cited by this paper
• RhoA Interacts with the Fusion Glycoprotein of Respiratory Syncytial Virus and Facilitates Virus-Induced Syncytium Formation

  1999cited by this paper
• Identification of a Linear Heparin Binding Domain for Human Respiratory Syncytial Virus Attachment Glycoprotein G

  1999influential reference
• Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor.

  1998cited by this paper
• Adaptation of Sindbis Virus to BHK Cells Selects for Use of Heparan Sulfate as an Attachment Receptor

  1998cited by this paper
• Regulated Diversity of Heparan Sulfate*

  1998cited by this paper
• A27L Protein Mediates Vaccinia Virus Interaction with Cell Surface Heparan Sulfate

  1998cited by this paper
• Cell Surface Proteoglycans Are Necessary for A27L Protein-Mediated Cell Fusion: Identification of the N-Terminal Region of A27L Protein as the Glycosaminoglycan-Binding Domain

  1998cited by this paper
• Binding of Sindbis Virus to Cell Surface Heparan Sulfate

  1998cited by this paper
• Heparin-Like Structures on Respiratory Syncytial Virus Are Involved in Its Infectivity In Vitro

  1998cited by this paper
• Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions

  1998cited by this paper
• Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

  1997cited by this paper
• Heparin-dependent attachment ofrespiratory syncytial virus (RSV) to host cells

  1997cited by this paper
• Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

  1997cited by this paper
• Virus-cell and cell-cell fusion.

  1996cited by this paper
• Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate

  1996cited by this paper
• Role of basic residues in the proteolytic activation of Sendai virus fusion glycoprotein.

  1995cited by this paper
• Cellular receptor structures for pseudorabies virus are blocked by antithrombin III

  1995cited by this paper
• Cell-Surface Heparan Sulfate Proteoglycan Mediates HIV-1 Infection of T-Cell Lines

  1993influential reference
• Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3

  1992cited by this paper
• Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin.

  1992cited by this paper
• Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradients.

  1991cited by this paper
• Syndecan, a cell surface proteoglycan, exhibits a molecular polymorphism during lung development.

  1991cited by this paper
• Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors.

  1990cited by this paper
• Initial interaction of herpes simplex virus with cells is binding to heparan sulfate

  1989cited by this paper
• Molecular Modeling of Protein‐Glycosaminoglycan Interactions

  1989cited by this paper
• Respiratory Syncytial Virus

  1988cited by this paper
• Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia.

  1988cited by this paper
• Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus.

  1987cited by this paper
• Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus.

  1987cited by this paper
• Sulfate transport-deficient mutants of Chinese hamster ovary cells. Sulfation of glycosaminoglycans dependent on cysteine.

  1986cited by this paper
• Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

  1986cited by this paper
• Kinetics of synthesis of respiratory syncytial virus glycoproteins.

  1985cited by this paper
• Animal cell mutants defective in glycosaminoglycan biosynthesis.

  1985cited by this paper
• Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus.

  1984cited by this paper
• Respiratory syncytial virus polypeptides. III. The envelope-associated proteins.

  1983cited by this paper
• Sulfated glycosaminoglycans of cells grown in culture: dermatan sulfate disappearance in successive fibroblast subcultures.

  1978cited by this paper
• Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus.

  1976cited by this paper
• Content and synthesis of glycosaminoglycans in the developing lung.

  1975cited by this paper

• New insight into the epidemiological trends of respiratory syncytial virus infection and the underlying anti-respiratory syncytial virus mechanisms of andrographolide: integrating Global Burden of Disease database, network pharmacological analysis, and in vitro experiments

  2025influential citation
• Evidence that an interaction between the respiratory syncytial virus F and G proteins at the distal ends of virus filaments mediates efficient multiple cycle infection.

  2024cites this paper
• Design of a New Vaccine Prototype against Porcine Circovirus Type 2 (PCV2), M. hyopneumoniae and M. hyorhinis Based on Multiple Antigens Microencapsulation with Sulfated Chitosan

  2024cites this paper
• Advanced fluorescence microscopy in respiratory virus cell biology.

  2023cites this paper
• Heparin mimetics as potential intervention for COVID-19 and their bio-manufacturing

  2022cites this paper
• Prefusion-specific antibody-derived peptides trivalently presented on DNA-nanoscaffolds as an innovative strategy against RSV entry

  2022cites this paper
• Impact of genetic polymorphisms related to innate immune response on respiratory syncytial virus infection in children

  2022cites this paper
• Functional Features of the Respiratory Syncytial Virus G Protein

  2021cites this paper
• Revisiting respiratory syncytial virus’s interaction with host immunity, towards novel therapeutics

  2020cites this paper
• TRIM22 inhibits respiratory syncytial virus replication by targeting JAK‐STAT1/2 signaling

  2020cites this paper
• Development of Luciferase Immunoprecipitation Systems (LIPS) Assay to Detect IgG Antibodies against Human Respiratory Syncytial Virus G-Glycoprotein

  2019cites this paper
• Alternative conformations of a major antigenic site on RSV F

  2019cites this paper
• Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?

  2019cites this paper
• Immunological goals for respiratory syncytial virus vaccine development.

  2019cites this paper
• Antigenic fingerprinting of RSV-A infected hematopoietic cell transplant recipients reveals importance of mucosal anti-RSV-G antibodies in control of RSV infection in humans.

  2019cites this paper
• Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane

  2019cites this paper
• Trapped! A Critical Evaluation of Methods for Measuring Total Cellular Uptake versus Cytosolic Localization.

  2019cites this paper
• New Insights for the Rational Design Of Human Respiratory Syncytial Virus Vaccines: From Molecular Biology to Clinical Trials

  2018cites this paper
• Host-pathogens interactions during RSV / S. pneumoniae infection immune response and p53 pathway

  2017cites this paper
• Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.

  2017cites this paper
• GENETIC AND ANTIGENIC CHARACTERISTICS OF RESPIRATORY SYNCYTIAL VIRUS STRAINS ISOLATED IN ST. PETERSBURG IN 2013-2016.

  2017cites this paper
• Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection

  2017cites this paper
• Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein

  2015cites this paper
• GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process

  2015cites this paper
• Polyclonal and monoclonal antibodies specific for the six-helix bundle of the human respiratory syncytial virus fusion glycoprotein as probes of the protein post-fusion conformation.

  2014cites this paper
• Development of a Luciferase Immunoprecipitation System Assay To Detect IgG Antibodies against Human Respiratory Syncytial Virus Nucleoprotein

  2014cites this paper
• Identification of cellular proteins that interact with Newcastle Disease Virus and human Respiratory Syncytial Virus by a two-dimensional virus overlay protein binding assay (VOPBA).

  2014cites this paper
• Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures

  2014influential citation
• Environmental modulation of mucosal immunity. Opportunities in respiratory viral infections

  2013influential citation
• Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry

  2013cites this paper
• A single amino acid in the F2 subunit of respiratory syncytial virus fusion protein alters growth and fusogenicity

  2013cites this paper
• HS N-sulfation and iduronic acids play an important role in the infection of respiratory syncytial virus in vitro.

  2013cites this paper
• Heparosan‐Derived Heparan Sulfate/Heparin‐Like Compounds: One Kind of Potential Therapeutic Agents

  2013cites this paper
• Cell‐Specific Targeting of Fusion Proteins through Heparin Binding

  2013cites this paper
• Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.

  2012cites this paper
• Identificação e caracterização molecular do virus sincicial respiratório humano em crianças com infecções respiratórias de 2006 a 2010

  2012cites this paper
• Inhibition of Human Respiratory Syncytial Virus Infectivity by a Dendrimeric Heparan Sulfate-Binding Peptide

  2012cites this paper
• Virus entry: old viruses, new receptors

  2012cites this paper
• Chapter 2 Heparan Sulfate Proteoglycans in Infection

  2011cites this paper
• Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells

  2011cites this paper
• Identification of nucleolin as a cellular receptor for human respiratory syncytial virus

  2011cites this paper
• Cholesterol-Rich Microdomains as Docking Platforms for Respiratory Syncytial Virus in Normal Human Bronchial Epithelial Cells

  2011cites this paper
• Heparan Sulfate Proteoglycans in Infection

  2011cites this paper
• Recombinant Sendai Viruses Expressing Fusion Proteins with Two Furin Cleavage Sites Mimic the Syncytial and Receptor-Independent Infection Properties of Respiratory Syncytial Virus

  2011cites this paper
• Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.

  2011cites this paper
• Sheng-Ma-Ge-Gen-Tang (Shoma-kakkon-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.

  2011cites this paper
• Soluble Respiratory Syncytial Virus Fusion Protein in the Fully Cleaved, Pretriggered State, a Tool to Study Protein Triggering

  2011cites this paper
• A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction

  2009cites this paper
• Prevention of respiratory syncytial virus infection via methoxypoly(ethylene glycol)-modification of the virus or its host cell

  2009cites this paper
• Microbial subversion of heparan sulfate proteoglycans.

  2008cites this paper
• Insertion of the Two Cleavage Sites of the Respiratory Syncytial Virus Fusion Protein in Sendai Virus Fusion Protein Leads to Enhanced Cell-Cell Fusion and a Decreased Dependency on the HN Attachment Protein for Activity

  2008cites this paper
• Heparin enhances the furin cleavage of HIV‐1 gp160 peptides

  2007influential citation